Shares of biotech companies involved in the development of monoclonal antibody cancer therapies were moving all over the ...

The New York-based public benefit corporation is advancing three drug candidates for the extremely rare condition.

The discussion also covers the significant potential of mRNA therapeutics in treating diseases like cancer and genetic disorders and challenges like stability and delivery.

Pivot to U.S.-based Supply Chain for Critical Input Materials Completed - STONY BROOK, NY / ACCESS Newswire / April 21, 2025 / Applied DNA ...

Cartesian Therapeutics, Inc.’s RNAC share price has dipped by 5.62%, which has investors questioning if this is right time to ...

Arcturus Therapeutics Holdings Inc.’s ARCT share price has surged by 6.84%, which has investors questioning if this is right ...

Emerging biotech leader AKESF develops Ivonescimab & Cadonilimab; while offering growth potential with US partnerships, ...

Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

Researchers from the International Institute of Molecular and Cell Biology in Warsaw (IIMCB) have described a new mechanism ...

Furthering its goal to grow the reach of its mRNA vaccines and guard against future pandemics, Moderna cleared a key ...